Concord Biotech Secures USFDA Approval for Teriflunomide Tablets

Unknown Apr 02, 2026 700 Views

Concord Biotech Limited has made a milestone achievement with the United States Food and Drug Administration (USFDA) approving marketing its Teriflunomide tablets. The approvals are for the 7 mg and 14 mg strengths, making Concord Biotech a significant player in managing relapsing forms of multip...